Restless legs syndrome: clinicoetiologic correlates

Neurology
W Ondo, J Jankovic

Abstract

Despite recent attempts to better characterize restless legs syndrome (RLS), this neurologic disorder remains poorly understood. The relationship between idiopathic and secondary and between familial and sporadic (nonfamilial) cases have not been previously defined. We studied 54 patients (29 women and 25 men) who satisfied the diagnostic criteria for RLS. The mean age of the patients was 62.69 +/- 13.82 years, and the mean age at onset was 34.13 +/- 20.30 years. We found that 92% of patients with idiopathic RLS (without neuropathy) had a family history of RLS, whereas only 13% of those with neuropathic RLS (associated with peripheral neuropathy) had a positive family history. The sporadic/neuropathic patients were older at symptom onset and tended to have a more rapid progression than the familial/idiopathic patients. There were no other significant differences between the subgroups. Levodopa and dopamine agonists were the most effective treatments. We conclude that there are two major etiologic subgroups of RLS but that the two share central pathophysiologic mechanisms.

Citations

Jan 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·A LazzariniW G Johnson
Dec 10, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·D L PicchiettiW A Hening
Apr 7, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·M MichaudJ Montplaisir
Apr 7, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·W OndoJ Mansoor
Oct 17, 2009·Inflammatory Bowel Diseases·Franco Gemignani
Mar 29, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Manavdeep GrewalColin Shapiro
Jan 9, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Carolina LombardiPasquale Montagna
Jun 8, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·E K TanK K Koh
Oct 16, 2007·Journal of Neurology·S HappeS Evers
May 16, 2009·Journal of Neurology·Claudia TrenkwalderJuliane Winkelmann
Sep 25, 2012·Journal of Neural Transmission·Angela RocoJosé A G Agúndez
Mar 20, 2002·Current Neurology and Neuroscience Reports·Wayne A Hening
Jul 1, 2005·Current Neurology and Neuroscience Reports·William G Ondo
Aug 6, 2008·MMW Fortschritte der Medizin·J Zeitlhofer
Apr 3, 2003·Current Treatment Options in Neurology·Mark W. Mahowald
Dec 4, 2003·Clinical Neurology and Neurosurgery·Ali AkyolNihat Ozgel
Mar 24, 2004·Parkinsonism & Related Disorders·E K TanD Khoo
Mar 7, 2001·Journal of the Neurological Sciences·F Gemignani, A Marbini
Apr 18, 2002·Journal of the Neurological Sciences·E K TanM C Wong
Aug 18, 2004·Sleep Medicine Reviews·R M Rijsman, A W de Weerd
Mar 15, 2001·Parkinsonism & Related Disorders·J L. AlbertsG E. Stelmach
Sep 2, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·R QuatraleE Granieri
Nov 1, 2003·Sleep Medicine·R P AllenC J Earley
Nov 1, 2003·Sleep Medicine·J Winkelmann
Nov 1, 2003·Sleep Medicine·W Ondo
Nov 1, 2003·Sleep Medicine·Dipankar BhowmikSuresh C Dash
Mar 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Makoto R HaraSolomon H Snyder
Mar 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hoon RyuAlpaslan Deodoglu
Nov 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Huai-hu Chuang, Stephanie Lin
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·A S MandirT M Dawson
Jul 4, 2001·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·R P Allen, C J Earley
Oct 24, 2002·Current Opinion in Pulmonary Medicine·Sanjiv Patel
Dec 21, 2004·International Journal of Clinical Practice·E K TanY L Lo
Oct 28, 2006·Postgraduate Medical Journal·V DhawanK R Chaudhuri
Mar 1, 2011·BMC Neurology·Diego Garcia-BorregueroMarco Zucconi
Dec 6, 2012·Translational Neurodegeneration·Tasneem Peeraully, Eng-King Tan
Mar 25, 2008·Therapeutics and Clinical Risk Management·Paul E Cotter, Shaun T O'Keeffe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.